To include your compound in the COVID-19 Resource Center, submit it here.

sanofi-aventis drops two Genfit compounds

sanofi-aventis (Euronext:SAN; NYSE:SNY) discontinued development of AVE8134 and AVE0847, which were developed with Genfit

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE